FDA approves first iOS app to control insulin pump
AppleInsider is supported by its audience and may earn commission as an Amazon Associate and affiliate partner on qualifying purchases. These affiliate partnerships do not influence our editorial content.
The U.S. Food and Drug Administration has cleared the first iOS and Android app capable of controlling a user’s insulin pump.
The app, t:connect, can be used in conjunction with Tandem Diabetes Care, Inc’s t:slim X2 insulin pump. The FDA-approved version allows a user to program and cancel bolus insulin requests through the convenience of their compatible smartphone.
The t:connect app previously allowed users to view their pump information on their iPhone. The app shows the last 24 hours of glucose trends, pump status changes, and insulin therapy data.
The t:connect app requires iOS 14 or later and currently is compatible with the t:slim X2 insulin pump.
Those who are curious about the Tandem Diabetes system are encouraged to download the t:simulator app, which allows a user to test drive Tandem’s touchscreen interface of the t:slim X2 insulin pump and preview the t:connect companion app’s functions.